Oculis Holding AG (OCS) Interest Expenses (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Interest Expenses of -$220921.8 in Q1 2026, up 26.73% quarter-over-quarter from -$301531.9 in Q4 2025, and up 19.58% on a YoY basis from -$184741.0 in Q1 2025.

Oculis Holding AG (OCS) Interest Expenses (2022 - 2026) Analysis & Trends

Oculis Holding AG's Interest Expenses history runs 5 years deep, the most recent figure standing at -$220921.8 for Q1 2026.

  • In Q1 2026, Interest Expenses rose 19.58% year-over-year to -$220921.8; the TTM figure through Mar 2026 stood at -$203.3 million (up 33.44% YoY), while the FY2025 annual figure was -$1.0 million, down 42.88% from the prior year.
  • Interest Expenses was -$220921.8 for Q1 2026 at Oculis Holding AG, up from -$301531.9 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of -$12453.7 in Q3 2023 to a low of -$304.7 million in Q3 2024.
  • Historically, Interest Expenses has averaged -$32.2 million across 5 years, with a median of -$278340.9 in 2025.
  • The sharpest annual moves came in 2023 and 2024: Interest Expenses surged 99.34% in 2023, then plunged 2446652.74% in 2024.
  • A 5-year view of Interest Expenses shows it stood at -$1.4 million in 2022, then surged by 99.01% to -$13528.3 in 2023, then plunged by 1984.2% to -$281955.9 in 2024, then declined by 6.94% to -$301531.9 in 2025, then increased by 26.73% to -$220921.8 in 2026.
  • The last three Interest Expenses figures came in at -$220921.8 (Q1 2026), -$301531.9 (Q4 2025), and -$202.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -5.50 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 61,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -332,000.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -2,753.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -5.58 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -220,921.81

Historic Data

Download Data
DateValue
Mar 31, 2026 -220,921.81
Mar 31, 2026 -220,921.81
Dec 31, 2025 -301,531.92
Dec 31, 2025 -301,531.92
Sep 30, 2025 -202.52 Mn
Sep 30, 2025 -202.52 Mn
Jun 30, 2025 -221,043.91
Jun 30, 2025 -221,043.91
Mar 31, 2025 -274,725.88
Mar 31, 2025 -274,725.88
Dec 31, 2024 -281,955.90
Dec 31, 2024 -281,955.90
Sep 30, 2024 -304.71 Mn
Sep 30, 2024 -304.71 Mn
Jun 30, 2024 -96,204.03
Jun 30, 2024 -96,204.03
Mar 31, 2024 -46,972.97
Mar 31, 2024 -46,972.97
Dec 31, 2023 -13,528.25
Dec 31, 2023 -13,528.25